Abstract
Purpose
To evaluate the clinical outcomes of patients with diffractive aspheric trifocal intraocular lens (AT.LISA tri839 MP® IOL, Carl Zeiss Meditec, Jena, Germany) implantation.
Methods
Forty eyes of 53 patients received phacoemulsification and implantation of AT.LISA tri839 MP® IOL (Carl Zeiss Meditec). Uncorrected distant visual acuity (UDVA), uncorrected intermediate visual acuity (UIVA), uncorrected near visual acui-ty (UNVA), refractive values, and defocus curve were evaluated at postoperative 1 month and 3 months. Optical quality was evaluated with the Optical Quality Analysis System (OQAS®, Visiometrics, Castelldefels, Spain).
Results
At the 3-month postoperative follow-up, the mean spherical equivalent was 0.01 ± 0.31 D and the mean UDVA, UIVA and UNVA were 0.023 ± 0.020, 0.155 ± 0.091, and 0.139 ± 0.069, respectively. The means of the objective scatter index, modu-lation transfer function cut-off value, Strehl ratio measured by OQAS® (Visiometrics) were 1.83 ± 0.52, 33.58 ± 14.27 cycle per degree and 0.18 ± 0.11, respectively. Intermediate visual acuity did not fall sharply at defocus curve.
References
1. Kim JH, Yu S, Koo SH. . Clinical outcomes of diffractive mul-tifocal toric intraocular lens implantation. J Korean Ophthalmol Soc. 2014; 55:1139–49.
2. Kim SM, Kim CH, Chung ES, Chung TY. Visual outcome and pa-tient satisfaction after implantation of multifocal IOLs: three-month follow-up results. J Korean Ophthalmol Soc. 2012; 53:230–7.
3. Kohnen T, Allen D, Boureau C. . European multicenter study of the AcrySof ReSTOR apodized diffractive intraocular lens. Ophthalmology. 2006; 113:584.e1.
4. Petermeier K, Messias A, Gekeler F. . Outcomes of the Acrysof ReSTOR IOL in myopes, emmetropes, and hyperopes. J Refract Surg. 2009; 25:1103–9.
5. Petermeier K, Szurman P. Subjective and objective outcome fol-lowing implantation of the apodized diffractive AcrySof ReSTOR. Ophthalmologe. 2007; 104:399–404. 406-8.
6. Law EM, Aggarwal RK, Kasaby H. Clinical outcomes with a new trifocal intraocular lens. Eur J Ophthalmol. 2014; 24:501–8.
7. Mojzis P, Peña-García P, Liehneova I. . Outcomes of a new dif-fractive trifocal intraocular lens. J Cataract Refract Surg. 2014; 40:60–9.
8. Kim YJ, Cheon MH, Ko DA. . Visual function and patient sat-isfaction in pseudophakic monovision. J Korean Ophthalmol Soc. 2012; 53:1621–9.
9. Lee HY, Her J. Clinical evaluation of monovision after cataract surgery. J Korean Ophthalmol Soc. 2008; 49:1437–42.
10. Kwon JW, Kang S, Chung SK, Baek NH. Clinical results of Crystalens(R) (AT-45) accommodating intraocular lens. J Korean Ophthalmol Soc. 2009; 50:1179–83.
11. Lee HS, Park SH, Kim MS. Clinical results and some problems of multifocal apodized diffractive intraocular lens implantation. J Korean Ophthalmol Soc. 2008; 49:1235–41.
12. Cumming JS, Slade SG, Chayet A. . Clinical evaluation of the model AT-45 silicone accommodating intraocular lens: results of feasibility and the initial phase of a Food and Drug Administration clinical trial. Ophthalmology. 2001; 108:2005–9.
13. Nakazawa M, Ohtsuki K. Apparent accommodation in pseudo-phakic eyes after implantation of posterior chamber intraocular lenses. Am J Ophthalmol. 1983; 96:435–8.
14. Trindade F, Oliveira A, Frasson M. Benefit of against-the-rule as-tigmatism to uncorrected near acuity. J Cataract Refract Surg. 1997; 23:82–5.
Table 1.
Table 2.
Value | p-value∗ | ||||
---|---|---|---|---|---|
Preop | 1 month | 3 months | Preop vs. 1 month | 1 month vs.3 months | |
Manifest sphere (D) | -0.11 ± 1.93 (-4.25, 2.25 | 5) 10.06 ± 0.25 (-0.75, 0.5) | 0.18 ± 0.24 (-0.75, 0.5) | 0.826 | 0.231 |
Manifest cylinder (D) | ) -0.69 ± 0.54 (-2.0, 0) | -0.36 ± 0.27 (-0.75, 0) | -0.39 ± 0.20 (-0.75, 0) | 0.003 | 0.535 |
Manifest S.E (D) | -0.39 ± 1.86 (-4.5, 1.875 | 5) -0.07 ± 0.28 (0.75, 0.5) | 0.01 ± 0.31 (-0.75, 0.5) | 0.626 | 0.507 |
UDVA (log MAR) | 0.54 ± 0.40 (0.04, 1) | 0.025 ± 0.021 (0, 0.155) | 0.023 ± 0.020 (0, 0.155) | 0.000 | 0.629 |
CDVA (log MAR) | 0.26 ± 0.29 (0, 1) | 0.008 ± 0.018 (0, 0.155) | 0.007 ± 0.011 (0, 0.155) | 0.000 | 0.353 |
UIVA (log MAR) | - | 0.167 ± 0.086 (0, 0.301) | 0.155 ± 0.091 (0, 0.301) | - | 0.428 |
UNVA (log MAR) | - | 0.141 ± 0.069 (0.097, 0.301 | 1) 0.139 ± 0.069 (0.097, 0.301) | - | 0.231 |
Values are presented as mean ± SD (range). Preop = preoperation; D = diopter; S.E = spherical equivalent; UDVA = uncorrected distance visual acuity at 4 m; log MAR = logarithm of the minimal angle of resolution; CDVA = corrected distance visual acuity at 4 m; UIVA = uncorrected intermediate visual acuity at 80 cm distance; UNVA = uncorrected near visual acuity at 40 cm distance.
Table 3.
Parameter | Values | p-value∗ | |
---|---|---|---|
1 month | 3 months | ||
OSI | 1.63 ± 0.60 | 1.83 ± 0.52 | 0.656 |
MTF cut-off (C/deg) | 31.15 ± 12.54 | 33.58 ± 14.27 | 0.822 |
Strehl ratio | 0.17 ± 0.08 | 0.18 ± 0.11 | 0.321 |